0001493152-20-016390.txt : 20200820
0001493152-20-016390.hdr.sgml : 20200820
20200820104409
ACCESSION NUMBER: 0001493152-20-016390
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200812
FILED AS OF DATE: 20200820
DATE AS OF CHANGE: 20200820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEINGARTEN ROBERT N
CENTRAL INDEX KEY: 0001135337
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51476
FILM NUMBER: 201119168
MAIL ADDRESS:
STREET 1: 5439 LOCKHURST DRIVE
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CENTRAL INDEX KEY: 0001335105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202903526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 248 ROUTE 25A
STREET 2: NO. 2
CITY: EAST SETAUKET
STATE: NY
ZIP: 11733
BUSINESS PHONE: 310 203 2902
MAIL ADDRESS:
STREET 1: 248 ROUTE 25A
STREET 2: NO. 2
CITY: EAST SETAUKET
STATE: NY
ZIP: 11733
FORMER COMPANY:
FORMER CONFORMED NAME: SRKP 7 INC
DATE OF NAME CHANGE: 20050803
3
1
ownership.xml
X0206
3
2020-08-12
0
0001335105
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT.OB
0001135337
WEINGARTEN ROBERT N
248 ROUTE 25A, NO. 2
EAST SETAUKET
NY
11733
0
1
0
0
Vice President and CFO
Options to Purchase Common Stock
1.19
2020-08-12
2025-08-12
Common Stock
87500
D
The Reporting Person was granted five-year options to purchase an aggregate of 350,000 shares of the Company's Common Stock vesting 25% on the date of grant and 25% on each anniversary of the grant.
/s/ ROBERT WEINGARTEN
2020-08-20